Evidence map›Paper›PMID 33875545›Full record

ArticleJournal of bacteriology2021

Inhibition of Escherichia coli Lipoprotein Diacylglyceryl Transferase Is Insensitive to Resistance Caused by Deletion of Braun's Lipoprotein.

Jingyu Diao, Rie Komura, Tatsuya Sano, Homer Pantua, Kelly M Storek, Hiroko Inaba, Haruhiko Ogawa, Cameron L Noland, Yutian Peng, Susan L Gloor and 18 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of bacteriology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Tandem amplification of theMicrobiology spectrum · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Novel Antibacterial Approaches and Therapeutic Strategies.Antibiotics (Basel, Switzerland) · 2025
    Review
  12. The BfmRS stress response protectsJournal of bacteriology · 2025
    Article
  13. Review
  14. Article
  15. Identification and characterization of the lipoproteinProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Identification and Characterization of the LipoproteinbioRxiv : the preprint server for biology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 1 institution in 1 country.

Jingyu DiaoDepartment of Infectious Diseases, Genentech, South San Francisco, California, USA.
Rie KomuraPeptidream Inc., Kawasaki, Kanagawa, Japan.
Tatsuya SanoPeptidream Inc., Kawasaki, Kanagawa, Japan.
Homer PantuaDepartment of Infectious Diseases, Genentech, South San Francisco, California, USA.
Kelly M StorekDepartment of Infectious Diseases, Genentech, South San Francisco, California, USA.
Hiroko InabaPeptidream Inc., Kawasaki, Kanagawa, Japan.
Haruhiko OgawaPeptidream Inc., Kawasaki, Kanagawa, Japan.
Cameron L NolandDepartment of Structural Biology, Genentech, South San Francisco, California, USA.
Yutian PengDepartment of Infectious Diseases, Genentech, South San Francisco, California, USA.
Susan L GloorDepartment of Biochemical and Cellular Pharmacology, Genentech, South San Francisco, California, USA.
Donghong YanDepartment of Translational Immunology, Genentech, South San Francisco, California, USA.
Jing KangDepartment of Translational Immunology, Genentech, South San Francisco, California, USA.
Anand Kumar KatakamDepartment of Pathology, Genentech, South San Francisco, California, USA.
Michael VolnyDepartment of Protein Chemistry, Genentech, South San Francisco, California, USA.
Peter LiuDepartment of Protein Chemistry, Genentech, South San Francisco, California, USA.
Nicholas N NickersonDepartment of Infectious Diseases, Genentech, South San Francisco, California, USA.
Wendy SandovalDepartment of Protein Chemistry, Genentech, South San Francisco, California, USA.
Cary D AustinDepartment of Pathology, Genentech, South San Francisco, California, USA.
Jeremy MurrayDepartment of Structural Biology, Genentech, South San Francisco, California, USA.
Steven T RutherfordDepartment of Infectious Diseases, Genentech, South San Francisco, California, USA.
Mike ReicheltDepartment of Pathology, Genentech, South San Francisco, California, USA.
Yiming XuDepartment of Biochemical and Cellular Pharmacology, Genentech, South San Francisco, California, USA.
Min XuDepartment of Translational Immunology, Genentech, South San Francisco, California, USA.
Hayato YanagidaPeptidream Inc., Kawasaki, Kanagawa, Japan.
Junichi NishikawaPeptidream Inc., Kawasaki, Kanagawa, Japan.
Patrick C ReidPeptidream Inc., Kawasaki, Kanagawa, Japan.
Christian N CunninghamDepartment of Early Discovery Biochemistry, Genentech, South San Francisco, California, USA.
Sharookh B KapadiaDepartment of Infectious Diseases, Genentech, South San Francisco, California, USA.
Peptidream (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipoprotein diacylglyceryl transferase (Lgt) catalyzes the first step in the biogenesis of Gram-negative bacterial lipoproteins which play crucial roles in bacterial growth and pathogenesis. We demonstrate that Lgt depletion in a clinical uropathogenic Escherichia coli strain leads to permeabilization of the outer membrane and increased sensitivity to serum killing and antibiotics. Importantly, we identify G2824 as the first-described Lgt inhibitor that potently inhibits Lgt biochemical activity

Indexed as

AnimalsAnti-Bacterial AgentsAspartic Acid EndopeptidasesBacterial ProteinsEscherichia coliFemaleGene DeletionGene Expression Regulation, BacterialLipoproteinsMicePeptidoglycanTransferasesUropathogenic Escherichia coliAnti-Bacterial AgentsAspartic Acid EndopeptidasesBacterial ProteinsLipoproteinsPeptidoglycanphosphatidylglycerol glyceryl transferasesignal peptidase IITransferasesantibiotic resistanceLgtlipoproteinsLpp

Identifiers

PMID33875545
PMCPMC8316002
OpenAlexW3156996922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.